UK markets closed

Alzamend Neuro, Inc. (ALZN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.6755-0.0191 (-2.75%)
At close: 04:00PM EDT
0.6755 0.00 (0.00%)
After hours: 06:25PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/04/2023
30/04/2022
30/04/2021
30/04/2020
Cash flows from operating activities
Net income
-12,589
-14,878
-12,362
-5,047
-4,410
Depreciation & amortisation
15.969
23.066
3.549
0
-
Stock-based compensation
3,972
3,583
4,409
2,032
1,802
Change in working capital
396.517
2,349
1,327
-152.451
-190.794
Other working capital
-8,333
-8,923
-6,720
-2,712
-2,346
Other non-cash items
-
-
12.77
517.05
453.724
Net cash provided by operating activities
-8,226
-8,923
-6,614
-2,712
-2,346
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-106.458
-
-
Other investing activities
-
-
-
100.915
105
Net cash used for investing activities
-147.243
0
-106.458
100.915
105
Cash flows from financing activities
Debt repayment
-
0
-58.667
-1.918
0
Common stock issued
4,000
0
18,911
2,100
2,288
Other financing activities
-
-
-
1,950
0.134
Net cash used provided by (used for) financing activities
3,943
0.2
18,855
4,450
2,288
Net change in cash
-4,390
-8,923
12,135
1,839
47.679
Cash at beginning of period
13,573
14,064
1,929
90.285
42.606
Cash at end of period
9,183
5,141
14,064
1,929
90.285
Free cash flow
Operating cash flow
-8,226
-8,923
-6,614
-2,712
-2,346
Capital expenditure
-
-
-106.458
-
-
Free cash flow
-8,333
-8,923
-6,720
-2,712
-2,346